In addition, in hepatic ischemia-reperfusion injury, octreotide and melatonin could reduce the inflammasome-induced pyroptosis by inhibiting the TLR4-NF-κB-NLRP3 pathway (46). Here, NLRP3 is linked to ischemia reperfusion injury.